Pharmaceuticals

Rotavirus Vaccine Market Outlook: Growth and Forecast Highlights 2030

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the rotavirus vaccine market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Rotavirus Vaccine Market covering 2026–2035?

The rotavirus vaccine market has experienced substantial growth in recent years. It is projected to expand from $10.14 billion in 2025 to $11.2 billion in 2026, at a compound annual growth rate (CAGR) of 10.4%. Historically, this market expansion can be attributed to the increasing incidence of pediatric gastroenteritis, the expansion of national immunization schedules, the growth of public health vaccination campaigns, the availability of live attenuated vaccines, and rising awareness of rotavirus prevention.

The rotavirus vaccine market is projected to experience substantial expansion over the coming years. This market is anticipated to reach a value of $16.45 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. Factors driving this growth during the projected period include a rising demand for universal pediatric vaccination, the development of more combination vaccines, increased investments in vaccine manufacturing capabilities, a heightened emphasis on achieving global immunization coverage, and greater collaboration with public health bodies. Key trends anticipated during the forecast period involve the wider expansion of pediatric immunization programs, the growing preference for oral vaccine formulations, a stronger focus on optimizing the vaccine cold chain, the expansion of public health vaccination efforts, and improved surveillance of rotavirus infections.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20617&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Rotavirus Vaccine Market?

Anticipated increases in birth rates are expected to drive the expansion of the rotavirus vaccine market in the coming period. Birth rates are defined as the annual number of live births per 1,000 individuals within a population. These rates are influenced by factors such as enhanced economic stability and growth, alongside supportive governmental policies like parental leave, child benefits, and childcare subsidies. The administration of rotavirus vaccines is instrumental in reducing the incidence of severe rotavirus gastroenteritis in infants, thereby improving child health outcomes and diminishing healthcare costs associated with rotavirus infections. As an illustration, in January 2023, a report from the Centers for Disease Control and Prevention, a US-based national public health organization, indicated that the United States observed a 1% increase in registered births, totaling 3,664,292, when compared to the preceding year. Thus, an upward trend in birth rates will propel the growth of the rotavirus vaccine market.

What Leading Segments Are Studied In The Rotavirus Vaccine Market?

The rotavirus vaccine market covered in this report is segmented –

1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types

2) By Application: Adult, Pediatric

3) By End Users: Hospitals, Clinics, Academic Research

Which Trends Are Influencing The Development Of The Rotavirus Vaccine Market?

Leading companies within the rotavirus vaccine market are increasingly adopting oral-dosing applicators to enhance the efficiency of vaccine delivery and improve compliance among patients. These applicators function as medical instruments designed to administer liquid medications or vaccines directly into the mouth, ensuring accurate dosing and ease of application, especially for infants and young children. For example, in June 2025, Micron Biomedical, a U.S.-based biotechnology company, and Emory University, a U.S.-based private university, initiated a first-in-human clinical trial for the inactivated rotavirus vaccine CC24, delivered using a dissolvable microarray patch. This patch is thermostable, thereby reducing dependence on cold chains, allows for self-administration, and generates no sharps waste. This advancement holds promise for increasing vaccine access in low-resource environments, although its regulatory pathways are yet to be established, and potential scale-up challenges could postpone its widespread implementation in the rotavirus vaccine market.

Which Major Industry Participants Are Leading The Rotavirus Vaccine Market Growth?

Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd. , SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/rotavirus-vaccine-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Rotavirus Vaccine Market?

North America was the largest region in the rotavirus vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Rotavirus Vaccine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20617&type=smp

Browse Through More Reports Similar to the Global Rotavirus Vaccine Market 2026, By The Business Research Company

Meningococcal Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report

Swine Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Typhoid Vi Polysaccharide Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795